Restricted accessResearch articleFirst published online 2020-10
Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin 1A receptor neurotransmission in the hippocampus
Cariprazine, the novel dopamine (DA) D3-preferring D3/D2 and serotonin (5-HT)1A receptor partial agonist, has activity as an adjunctive therapy in major depressive disorder (MDD).
Aims:
This study aims to investigate the effects of chronic cariprazine administration in combination with the selective serotonin reuptake inhibitor escitalopram on the activity of monoaminergic systems.
Methods:
Rats received cariprazine alone and in adjunct to escitalopram for 2 and 14 days and the firing activity of dorsal raphe nucleus 5-HT, locus coeruleus norepinephrine (NE) and ventral tegmental area DA neurons was assessed. 5-HT and NE neurotransmission in hippocampus pyramidal neurons was evaluated by assessing tonic activation of their 5-HT1A, and α1- and α2-adrenergic receptors, using their selective antagonists.
Results:
Two and 14-day cariprazine regimens increased the firing rate of NE, but not 5-HT and DA neurons. Addition of cariprazine to escitalopram reversed the inhibitory effect of escitalopram on NE but not 5-HT and DA neurons. In the hippocampus, there was an increase in neurotransmission at 5-HT1A receptors in cariprazine-treated rats, but no change in overall NE transmission by either regimen.
Conclusion:
Cariprazine increased NE neuronal firing and reversed the escitalopram-induced inhibition of these neurons. Despite a lack of effect on 5-HT neuronal firing activity, there was an increase in tonic activation of hippocampus 5-HT1A receptors by cariprazine alone but not with the combination. These effects provide a possible rationale for the clinical efficacy of cariprazine as an adjunctive strategy in patients with MDD.
AghajanianGKVandermaelenCP (1982) Intracellular recording in vivo from serotonergic neurons in the rat dorsal raphe nucleus: Methodological considerations. J Histochem Cytochem30: 813–814.
2.
AmanTKShenRYHaj-DahmaneS (2007) D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance. J Pharmacol Exp Ther320: 376–385.
3.
BessonAHaddjeriNBlierP, et al. (2000) Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol10: 177–188.
4.
BlierPBlondeauC (2011) Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder. J Affect Disord128: 3–10.
5.
BlierPde MontignyC (1990) Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: Single-cell recording studies. J Clin Psychopharmacol10: 13S–20S.
6.
BlierPWardNM (2003) Is there a role for 5-HT1A agonists in the treatment of depression?Biol Psychiatry53: 193–203.
7.
ChernolozOEl MansariMBlierP (2009) Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. Psychopharmacology (Berl)206: 335–344.
8.
ChernolozOEl MansariMBlierP (2012) Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission. Neuropsychopharmacology37: 1717–1728.
9.
ChoiYKAdhamNKissB, et al. (2014) Long-term effects of cariprazine exposure on dopamine receptor subtypes. CNS Spectr19: 268–277.
10.
CitromeL (2015) The ABC’s of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: The 15-min challenge to sort these agents out. Int J Clin Pract69: 1211–1220.
11.
CuretOde MontignyC (1988) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine microiontophoretically applied norepinephrine. Brain Res475: 35–46.
12.
DelcourteSAshbyCRJrRoveraR, et al. (2018) The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity. CNS Neurosci Ther24: 1129–1139.
13.
DemirevaEYSuriDMorelliE, et al. (2018) 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy. Mol Psychiatry. Epub ahead of print 17 Aug 2018. DOI: 10.1038/s41380-018-0227.
14.
de MontignyCWangRYReaderTA, et al. (1980) Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res200: 363–376.
15.
Di MatteoVDe BlasiADi GiulioC, et al. (2001) Role of 5-HT2C receptors in the control of central dopamine function. Trends Pharmacol Sci22: 229–232.
16.
DongJde MontignyCBlierP (1997) Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: Electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn-Schmiedeberg’s Arch Pharmacol356: 303–311.
17.
DongJde MontignyCBlierP (1998) Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe. J Pharmacol Exp Ther286: 1239–1247.
18.
DremencovEEl MansariMBlierP (2007) Noradrenergic augmentation of escitalopram response by risperidone: Electrophysiologic studies in the rat brain. Biol Psychiatry61: 671–678.
19.
DremencovEEl MansariMBlierP (2009) Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci34: 223–229.
20.
DurgamSEarleyWGuoH, et al. (2016) Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: A randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder. J Clin Psychiatry77: 371–378.
21.
DuricVBanasrMFranklinT, et al. (2017) Cariprazine exhibits anxiolytic and dopamine D3 receptor-dependent antidepressant effects in the chronic stress model. Int J Neuropsychopharmacol20:788–796.
22.
EarleyWRGuoHNémethG, et al. (2018) Cariprazine augmentation to antidepressant therapy in major depressive disorder: Results of a randomized, double-blind, placebo-controlled trial. Psychopharmacol Bull48: 62–80.
23.
EbrahimzadehMEl MansariMBlierP (2018) Synergistic effect of aripiprazole and escitalopram in increasing serotonin but not norepinephrine neurotransmission in the rat hippocampus. Neuropharmacology146: 12–18.
24.
El MansariMGhanbariRJanssenS, et al. (2008) Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology55: 1191–1198.
25.
El MansariMSánchezCChouvetG, et al. (2005) Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in the rat brain. Neuropsychopharmacology30: 1269–1277.
26.
FlorescoSBWestARAshB, et al. (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci6: 968–973.
27.
GhanbariREl MansariMBlierP (2010) Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons. J Psychopharmacol24: 39–50.
28.
GhanbariREl MansariMBlierP (2011) Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology (Berl)217: 61–73.
29.
GraceAABunneyBS (1984) The control of firing pattern in nigral dopamine neurons: Single spike firing. J Neurosci4: 2866–2876.
30.
GraceAABunneyBSMooreH, et al. (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci20: 31–37.
31.
HaddjeriNBlierPde MontignyC (1998) Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci18: 10150–10156.
32.
HadravaVBlierPde MontignyC (1994) Agonist occupation of serotonin1A receptors in the rat hippocampus prevents their inactivation by pertussis toxin. Neuroscience61: 21–30.
33.
HajosMSharpT (1996) Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: Electrophysiological analysis by antidromic stimulation. Brain Res740: 162–168.
34.
HermanAEl MansariMAdhamN, et al. (2018) Involvement of 5-HT1A and 5-HT2A receptors but not α2-adrenoceptors in the acute electrophysiological effects of cariprazine in the rat brain in vivo. Mol Pharmacol94: 1363–1370.
35.
HuangMHeWKissB, et al. (2019) The role of dopamine D3 Receptor partial agonism in cariprazine-induced neurotransmitter efflux in rat hippocampus and nucleus accumbens. J Pharmacol Exp Ther371:517–525.
36.
KehrJYoshitakeTIchinoseF, et al. (2018) Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity. Psychopharmacology (Berl)235: 1593–1607.
37.
KandelERSpencerWA (1961) Electrophysiology of hippocampal neurons. II. After potential and repetitive firing. J Neurophysiol24: 243–259.
38.
KissBHorváthANémethyZ, et al. (2010) Cariprazine (RGH-188), a dopamine D(3) receptor- preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: In vitro and neurochemical profile. J Pharmacol Exp Ther33: 3328–3340.
39.
LejeuneFNewman-TancrediAAudinotV, et al. (1997) Interactions of (+)-and (−)-8-and 7-hydroxy-2-(di-n-propylamino) tetralin at human (h) D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. J Pharmacol Exp Ther280: 1241–1249.
40.
LismanJEGraceAA (2005) The hippocampal-VTA loop: Ccontrolling the entry of information into long-term memory. Neuron46: 703–713.
41.
MarwahaJAghajanianGK (1982) Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther222: 287–293.
42.
MoreinesJLOwrutskyZLGagnonKG, et al. (2017) Divergent effects of acute and repeated quetiapine treatment on dopamine neuron activity in normal vs. chronic mild stress induced hypodopaminergic states. Transl Psychiatry7: 1275–1283.
43.
NelsonJCPapakostasGO (2009) Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry166: 980–991.
44.
NuttDJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry69: 4–7.
45.
OosterhofCAEl MansariMBlierP (2014) Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization. J Pharmacol Exp Ther351: 585–595.
46.
OosterhofCAEl MansariMBlierP (2015) Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: An in vivo electrophysiological characterization. Eur Neuropsychopharmacol254: 531–543.
47.
OosterhofCAEl MansariMBundgaardC, et al. (2016) Brexpiprazole alters monoaminergic systems following repeated administration: An in Vivo electrophysiological study. Int J Neuropsychopharmacol19: 1–12.
48.
PappMGrucaPLasoń-TyburkiewiczM, et al. (2014) Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression. Behav Pharmacol25: 567–574.
49.
PaxinosGWatsonC (2007) The Rat Brain in Stereotaxic Coordinates. 4th ed.London: Academic press.
50.
PiñeyroGBlierPDennisT, et al. (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci14: 3036–3047.
51.
RanckJB (1975) Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats. In: IsaacsonRLPribramKH (eds.), The Hippocampus. New York, NY: Plenum Publishing, pp. 207–244.
52.
RogóżZ (2013) Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: Preclinical and clinical efficacy. Pharmacol Rep65: 1535–1544.
53.
SchultzW (1998) Predictive reward signal of dopamine neurons. J Neurophysiol80: 1–27.
54.
SeagerMABarthVNPhebusLA, et al. (2005) Chronic co-administration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: Implications for bipolar disorder. Psychopharmacology (Berl)181: 126–133.
55.
SeagerMAHuffKDBarthVN, et al. (2004) Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity. Biol Psychiatry55: 1103–1109.
56.
SekineYSuzukiKRamachandranPV (2007) Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study. Synapse61: 72–77.
57.
SonnenscheinSFGillKMGraceAA (2018) State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia. Neuropsychopharmacology44: 572–580.
58.
SzabadiE (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol27: 659–693.
59.
SzaboSTBlierP (2001a) Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res922: 9–20.
60.
SzaboSTBlierP (2001b) Serotonin 1A receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABAA receptors: A microiontophoretic study in the rat locus coeruleus. Synapse42: 203–212.
61.
SzaboSTBlierP (2002) Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT2A receptor antagonism on the firing activity of norepinephrine neurons. J Pharmacol Exp Ther302: 983–991.
62.
SzaboSTde MontignyCBlierP (2000) Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol3: 1–11.
63.
ThaseMEBowdenCLNashatM, et al. (2012) Aripiprazole in bipolar depression: A pooled, post-hoc analysis by severity of core depressive symptoms. Int J Psychiatry Clin Prac16: 121–131.
64.
UnglessMAGraceAA (2012) Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci35: 422–430.
65.
ValentiOLodgeDJGraceAA (2011) Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus. J Neurosci31: 4280–4289.
66.
ZoharJStahlSMollerHJ, et al. (2015) A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. Eur Neuropsychopharmacol25: 2318–2325.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
